IFIT3 and acute promyelocytic leukemia: Studies have shown that RIG-G is a growth inhibitor for APL cells, acting to upregulate the expression of cell cycle inhibitors p21 and p27, thereby contributing toward anti-proliferation and cell differentiation [9,10].